Adenosine Deaminase Severe Combined Immunodeficiency
ADA-SCID
📋Overview
Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) is a rare genetic disorder characterized by a deficiency of the enzyme adenosine deaminase (ADA), leading to severe impairment of the immune system. ADA-SCID is a subtype of Severe Combined Immunodeficiency (SCID), a group of disorders causing profound defects in both T-cell and B-cell immunity. This condition results in extreme vulnerability to infections early in life. ADA deficiency leads to toxic metabolite accumulation that damages lymphocytes, causing immune failure.
🛡️ Educational information only
This content is provided for general health education and awareness and is based on publicly available medical information. It is not intended to replace professional medical advice, diagnosis, or treatment, and should not be used to make healthcare decisions. Always seek the guidance of a qualified healthcare professional regarding any medical condition, medication, supplement, or procedure.
Sections:
Additional Resources
Medical codes (for reference)
UMLS CUI: C0392607ICD-10-CM
D81.31
MeSH
C531816
SNOMED CT (US)
22406001
Codes are provided for reference and interoperability. They are not a diagnosis.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.